Deborah Cenci

Chief Executive Officer and Chief Compliance Officer

Professional Overview

Deborah Cenci is a seasoned executive with extensive expertise in the pharmaceutical industry, specializing in regulatory affairs, quality, and compliance. As the Chief Executive Officer and Chief Compliance Officer at DIVA Pharmaceuticals, Inc., she leverages her deep industry knowledge and strategic leadership to drive the company's success.

Experience Summary

Current Role

As the Chief Executive Officer and Chief Compliance Officer at DIVA Pharmaceuticals, Inc., Deborah is responsible for the overall strategic direction and compliance oversight of the organization. She provides visionary leadership, ensuring the company's operations adhere to the highest regulatory standards while fostering a culture of excellence and innovation.

Career Progression

Deborah's career spans over three decades, with a consistent focus on the pharmaceutical industry. Prior to her current role, she served as the A.V.P of Regulatory Affairs, Quality and Compliance at Capgemini, where she played a pivotal role in enhancing the company's life sciences practice. She also held senior positions at DIVA Pharmaceuticals, Inc., HCL Technologies, Thermo Fisher Scientific, and prestigious accounting firms like E&Y and Coopers & Lybrand, further solidifying her expertise in regulatory affairs, compliance, and quality management.

Academic Background

Deborah holds a Bachelor's degree in Business Technology from a reputable institution, supplementing her extensive industry experience with a strong academic foundation.

Areas of Expertise

• Regulatory affairs and compliance

• Quality management and assurance

• Pharmaceutical product development and commercialization

• Strategic planning and organizational leadership

• Cross-functional collaboration and team management

Professional Impact

Throughout her career, Deborah has spearheaded numerous successful initiatives, including the implementation of robust compliance programs, the streamlining of regulatory processes, and the successful launch of several pharmaceutical products. Her contributions have significantly improved the operational efficiency and compliance posture of the organizations she has served, solidifying her reputation as a trusted industry leader.

Conclusion

Deborah Cenci's exceptional track record, combined with her unwavering commitment to excellence, positions her as a valuable asset to DIVA Pharmaceuticals, Inc. As the Chief Executive Officer and Chief Compliance Officer, she is poised to leverage her expertise to drive the company's continued growth and success in the ever-evolving pharmaceutical landscape.